One of Kalorama's best-selling market research reports, this report provides the reader with a complete analysis of the domestic and international markets for pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatological Drugs is the sixth time Kalorama Information has comprehensively studied the dermatology markets.

Kalorama has completely re-evaluated the market from the ground up, and in addition to the usual primary research (interviews) of industry participants, clinicians, and regulators, we also conducted scores of interviews with users of Kalorama’s 2004 and 2006 dermatological studies to ensure that the current report contains the best possible data and the most useful analysis.

In this new edition, various shifts in the market are noted. There is information on bilogics, discussion of fillers and of treatments for skin infections such as MRSA. New companies have been added and consolidations in the industry have been addressed.

Market information is available for the years 2004 to 2011, with the focus year 2006 for competitive analysis. Overview and product descriptions of general therapy segments are covered, including prescription drugs to treat:

• Acne and Rosacea
• Antiaging and Photodamage
• Dermatitis and Seborrhea
• Fungal Infections
• Hair Loss and Hair Removal
• Hyperpigmentation/Melasma
• Psoriasis
• Skin Cancer, and
• Other Skin Disorders

Other data points include competitive market share, demographics, epidemiology, and geographic break down, which provide revenues for four regions:

• United States
• Europe
• Japan
• Rest of world

The study covers issues and trends affecting the market, research and developments, and more. In particular, the study explores the current and potential effects of the aging baby boomers on the prescription dermatology market and the continued demand for lifestyle drugs. Profiles of major market participants are included, including:

• Allergan Inc.
• Allergan Inamed Corporation
• Barrier Therapeutics, Inc
• Bayer AG
• Bradley Pharmaceuticals, Inc
• Bristol-Myers Squibb
• CollaGenex Pharmaceuticals
• Galderma S.A.
• Genentech, Inc.
• GlaxoSmithKline Plc
• Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
• Medicis Pharmaceutical Corporation
• Merck & Company, Inc.
• Mylan Pharmaceuticals, Inc,
• Novartis Pharmaceuticals Corporation
• Nycomed Inc.
• Pfizer, Inc.
• Q-Med AB
• Roche Group (F. Hoffmann-La Roche Ltd.)
• Schering-Plough Corporation
• Sinclair Pharma Plc.
• SkinMedica
• Stiefel Laboratories, Inc.
• Valeant Pharmaceuticals, Inc.

Related Reports:

The Worldwide Market for Cancer Diagnostics, 4th Edition
Apr 1, 2010 - KLI2504623 - $4,200.00

The Global Market for Medical Devices
Mar 1, 2010 - KLI2592223 - $1,500.00

The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
Oct 1, 2009 - KLI2435380 - $3,500.00

2009 Worldwide Diagnostics Market Research Bundle
Oct 1, 2009 - KLI2401913 - $5,995.00

The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets
Oct 1, 2009 - KLI2384194 - $3,995.00

Implant-Based Dental Reconstruction: World Dental Implant and Bone Graft Market, 3rd Edition
Sep 1, 2009 - KLI2284095 - $3,500.00

Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Jun 1, 2009 - KLI2155319 - $3,995.00

The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
May 1, 2009 - KLI2218043 - $3,995.00

Rx to OTC Switches 2009
May 1, 2009 - KLI2196300 - $3,500.00

World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)
May 1, 2009 - KLI1829596 - $3,500.00